Unique ID issued by UMIN | UMIN000004690 |
---|---|
Receipt number | R000005580 |
Scientific Title | The effect of tramadol on patients with septic shock caused by generalized peritonitis |
Date of disclosure of the study information | 2010/12/13 |
Last modified on | 2010/12/08 18:01:24 |
The effect of tramadol on patients with septic shock caused by generalized peritonitis
The effect of tramadol on patients with septic shock caused by generalized peritonitis
The effect of tramadol on patients with septic shock caused by generalized peritonitis
The effect of tramadol on patients with septic shock caused by generalized peritonitis
Japan |
Sepsis
Anesthesiology | Intensive care medicine | Adult |
Others
NO
The aim of this study is to examine the effect of perioperative administration of tramadol to patients with septic shock caused by generalized peritonitis on hemodynamics and dosage of vasopressor.
Efficacy
The norepinephrine requirement during and after surgery
Organ dysfunction score, infusion volume, urinary output, and cardiovascular drugs requirement
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
Numbered container method
2
Treatment
Medicine |
Tramadol 2mg/kg is administered intramuscularly after induction of anesthesia. Since then, same dose of tramadol is administered iteratively every five hours until discharge from the intensive care unit or for up to 48 hours after surgery. Hemodynamic responses around tramadol administration, cardiovascular drug requirement, infusion volume, urine output, and organ dysfunction score is recorded.
Saline 0.04ml/kg is administered intramuscularly after induction of anesthesia. Since then, same dose of tramadol is administered iteratively every five hours until discharge from the intensive care unit or for up to 48 hours after surgery. Hemodynamic responses around saline administration, cardiovascular drug requirement, infusion volume, urine output, and organ dysfunction score is recorded.
18 | years-old | <= |
Not applicable |
Male and Female
After obtaining written informed consent from the patients' next of kin, ASA physical status 1 - 3 patients with generalized peritonitis who are scheduled to undergo the surgery are prospectively enrolled in this study.
P1 A normal healthy patient
P2 A patient with mild systemic disease
P3 A patient with severe systemic disease
P4 A patient with severe systemic disease that is a constant threat to life
P5 A moribund patient who is not expected to survive without the operation
P6 A declared brain-dead patient whose organs are being removed for donor purposes
1) Age of younger than 18 years
2) Pregnancy
3) Allergy to scheduled drugs
4) Previous history of severe kidney and/or liver disease
5) Previous sulfonylurea use
6) Current use of anticonvulsant drugs
7) Inappropriate patients for study judged by the physicians
60
1st name | |
Middle name | |
Last name | Hiroshi Iranami |
Japanese Red Cross Society Wakayama Medical Center
Department of Anesthesiology
Komatsubara-dori 4-20, Wakayama, Wakayama 640-8558, Japan
1st name | |
Middle name | |
Last name | Hiroshi Iranami |
Japanese Red Cross Society Wakayama Medical Center
Department of Anesthesiology
Komatsubara-dori 4-20, Wakayama, Wakayama 640-8558, Japan
073-422-4171
Japanese Red Cross Society Wakayama Medical Center
Department of Anesthesiology
none
Self funding
NO
日本赤十字社和歌山医療センター
2010 | Year | 12 | Month | 13 | Day |
Unpublished
Preinitiation
2010 | Year | 12 | Month | 08 | Day |
2010 | Year | 12 | Month | 01 | Day |
2010 | Year | 12 | Month | 08 | Day |
2010 | Year | 12 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005580